NEW YORK (GenomeWeb) – The National Institutes of Health this week proposed receiving an additional $323 million in Alzheimer's disease funding over what has already been budgeted for the agency in fiscal 2017, stating that the additional money would significantly accelerate research into a disease that is expected to affect more than 65 million people worldwide by 2030.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

An opinion piece in the Guardian argues that President Donald Trump is uninterested in science and that might not be a bad thing for the field.

The San Francisco Chronicle reports the Veterans Affairs Health System is studying whether genetic testing can help prescribe better depression therapies.

Stat News reports that Spark Therapeutics' Luxturna is now being used to treat a wider array of patients.

In Genome Biology this week: transcription factor use among brittle stars, single-cell RNA sequencing strategy, and more.